Report Scope:
This report will provide a detailed overview of ovarian cancer, highlighting treatment guidelines with information on the current and potential global market for ovarian cancer and treatments and testing technologies with detailed analysis of the competitive landscape, including new potential markets for novel products, diagnostics and therapeutics development.
The report covers the regulatory environment, current and new technologies, ovarian cancer incidence, market projections and market share along with the latest trends and new developments, recent approvals, the research and development pipeline, and blockbuster drugs. It also covers global and regional markets for ovarian cancer diagnostics and therapies, providing reasons for variations in the growth of the industry across regions.
The report also analyzes the competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include AbbVie Inc, Astra Zeneca, Bristol-Myers Squibb Company, Celgene Corp., Clovis Oncology, Eli Lilly and Company, GlaxoSmithKline plc, Hikma Pharmaceuticals PLC, Janssen Pharmaceuticals, Inc., Merck & Company, Inc., Myriad Genetics Inc., Novartis AG, Pfizer, Inc., Quest Diagnostics Inc., Roche Holding AG and Tesaro, Inc.
Report Includes:
- 28 data tables and 9 additional tables
- A comprehensive analysis of the ophthalmic device market by reviewing recent advances in diagnostic, surgical, and implantation devices that can be used to treat prevalent eye conditions.
- Analyses of global market trends with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022.
- Breakdowns of the market by device, application, and region.
- Analysis of the recent advances in ophthalmic medical devices and their potential impact on the medical device industry.
- Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities.
- Company profiles of major players in the market, including AbbVie Inc., Bristol-Myers Squibb, Clovis Oncology, Inc., Eli Lilly and Company and Pfizer Inc.
Reasons for Doing This Study
This study was conducted to provide detailed information regarding screening, testing and treatment options for ovarian disorders and cancer. There is an increasing need for new and innovative technologies, while this industry is experiencing tremendous growth. Many diseases discussed in this report are global issues, and a need exists for newer diagnostic and treatment strategies. This study looks at most types of diagnostic and treatment strategies for the clinical management of ovarian disorders and related cancers.
This BCC Research market research report will increase the awareness of current and emerging drugs and technologies for ovarian cancers, including therapeutics, chemotherapy and surgical therapy.
Therapies and Diagnostics for Ovarian Cancer: Global Markets to 2022
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Market Context for Ovarian Cancer Therapies and Diagnostics
Chapter 3 Overview and Biology
Overview
Biology
Metastasis
Risk Factors
Family History
Genetic Mutation
Lynch Syndrome
Peutz-Jeghers Syndrome
Age
Previous Conditions
Prevention
Birth Control
Childbearing Status
Removal of the Ovaries and Fallopian Tubes
Hysterectomy/Tubal Ligation
Symptoms
Gastrointestinal
Abdominal
Whole Body
Diagnosis
Overview
Current Screening Practices
Stages of Ovarian Cancer
Stage I
Stage II
Stage III
Stage IV
Chapter 4 Market Dynamics and Technology Background
Market Definition and Overview
Market Drivers
Increase in Healthcare Expenditures
Continued Emphasis on R&D activities in Cancer and Treatment Technologies
Promised Potential of Alternative Therapies
Greater Understanding of the Genetic Base of lndividual Cancers
Increasing incidences of Ovarian Cancer Worldwide
Greater Use of Combination Therapies for Treatment
Increasing Cancer Prevalence Rates and Aging Population
Rising Awareness Among People with Cancer and Its Treatment
Market Restraints
Lack of Accurate Diagnosis of Ovarian Cancer
The Launch of Generic Drugs
Market Opportunities
Rising Female Population in the Asia-Pacific Region
Aging Demographics in Japan
Technological Advancements in the Drug Sector
Emergence of New Therapies for Disease Control
Chapter 5 Market Breakdown by Diagnosis
Overview
Background
Diagnostic Tests
Pelvic Exam
Laboratory Tests
Recurrent Ovarian Epithelial Cancer
Market Forecast
New Developments
Chapter 6 Ovarian Cancer Treatment
Treatment Strategies for Ovarian Cancer
Current Treatment Practices
Surgery
Chemotherapy
Intraperitoneal Chemotherapy
IV Chemotherapy
Targeted Therapy
Immunotherapy
Radiation Therapy
Palliative/Supportive Care
Recurrent Ovarian Cancer
Metastatic Ovarian Cancer
Sensitive Cancer Treatment
Resistant Cancer Treatment
Recurrent Ovarian Epithelial Cancer
Secondary Chemotherapy Drugs
Surveillance After Treatment
Novel Strategies for Prevention of Multidrug Resistance (MDR) in Cancer
Chapter 7 Market Breakdown by Cancer Type
Epithelial Ovarian Tumors
Germ Cell Tumors
Stromal Tumors
Primary Peritoneal Cancer
Stages of Ovarian Cancer
Stage 1
Stage 2
Stage 3
Stage 4
Prognosis
Chapter 8 Market Breakdown by Region
Introduction
North America
U.S.
Canada
Europe
Acquisitions and Collaborations
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
India
China
Japan
Middle East & Africa
Drivers
Restraints
Latin America
Mexico
Drivers
Restraints
Chapter 9 Pipeline Analysis
Current Scenario
New Product Developments
VEGF Inhibitor
PARP Inhibitors
Promising Pipeline Molecules/Drugs in Development
Atezolizumab
Avelumab
Lurbinectedin
Veliparib
Trametinib
Fosbretabulin
Mirvetuximab Soravtansine
Most Promising Drug
ONX-0801
Recent Developments in the Ovarian Cancer Treatment
Gene Therapy Inhibited Chemoresistant Tumor
Synthetic Gene Circuit Development
Novel Combination Therapy
Birinapant
CancerSEEK
Chapter 10 Patent Analysis
Overview
Patent Expiration
Chapter 11 Competitive Landscape and Key Developments
Overview
Major Players and Market Share
Mergers and Acquisitions
AbbVie and Stemcentrx
Hikma Pharmaceuticals and EIMC United Pharmaceuticals
Roche and Ignyta
Chapter 12 Company Profiles
ABBVIE INC.
Business Overview
Products and Services
Imbruvica
Venclexta
Pipeline analysis
Acquisitions
Financials
ASTRA ZENECA
Business Overview
Products and Services
Tagrisso
Lynparza
Faslodex (Fulvestrant)
Zoladex
Ovarian Cancer Products
Developments and Strategies
Financials
BRISTOL-MYERS SQUIBB
Business Overview
Products and Services
Developments and Strategies
Financials
CELGENE CORP.
Business Overview
Products and Services
Financials
CLOVIS ONCOLOGY
Business Overview
Products and Services
ELI LILLY AND COMPANY
Business Overview
Products and Services
Gemzar
Developments and Strategies
Financials
GLAXOSMITHKLINE PLC
Business Overview
Developments and Strategies
Acquisition
Financials
HIKMA PHARMACEUTICALS PLC
Business Overview
Products and Services
Developments and Strategies
Acquisitions
Financials
JANSSEN PHARMACEUTICALS, INC.
Business Overview
Financials
MERCK & CO., INC.
Business Overview
Financials
MYRIAD GENETICS INC.
Business Overview
Products and Services
Financials
NOVARTIS AG
Business Overview
Products and Services
Financials
PFIZER INC.
Company Overview
Financials
QUEST DIAGNOSTICS INC.
Business Overview
Products and Services
Financials
ROCHE HOLDING AG
Business Overview
Products and Services
Acquisitions
Financials
TESARO, INC.
Business Overview
Products and Services
Immuno-Oncology Platform
List of Tables
Summary Table A : Global Ovarian Cancer Therapeutic Market, by Cancer Type, Through 2022
Summary Table B : Global Ovarian Cancer Therapeutic Market, by Region, Through 2022
Table 1 : Imaging Tests and Functionality
Table 2 : Global Market for FDA Cleared/Approved Companion Diagnostic Devices for Cancer, by Category, Through 2022
Table 3 : Global Ovarian Cancer Therapeutics Market, by Cancer Type, Through 2022
Table 4 : Stage 1 and Substages of Ovarian Cancer
Table 5 : Stage 2 and Substages of Ovarian Cancer
Table 6 : Stage 3 and Substages of Ovarian Cancer
Table 7 : Stage 4 and Substages of Ovarian Cancer
Table 8 : Global Ovarian Cancer Therapeutics Market, by Region, Through 2022
Table 9 : North America Ovarian Cancer Therapeutics Market, Through 2022
Table 10 : Europe Ovarian Cancer Therapeutics Market, Through 2022
Table 11 : Asia-Pacific Ovarian Cancer Therapeutics Market, Through 2022
Table 12 : Middle East and Africa Ovarian Cancer Therapeutics Market, Through 2022
Table 13 : Latin America Ovarian Cancer Therapeutics Market, Through 2022
Table 14 : PARP Inhibitors
Table 15 : Pipeline Drugs Summary, by Phase
Table 16 : Global Sales at Risk from Patent Expiration, 2016-2022
Table 17 : Drugs Scheduled to Lose Patent Protection, 2018
Table 18 : Drugs Scheduled to Lose Patent Protection, 2019
Table 19 : Oncology Segment Revenue of Major Players, 2016
Table 20 : AbbVie Inc.'s Revenue, 2015-2016
Table 21 : AstraZeneca's Revenue, 2015-2016
Table 22 : Lynparza's Revenue, 2015-2016
Table 23 : Bristol-Myers Squibb's Revenue, 2015-2016
Table 24 : Celgene Corp.'s Revenue, 2015-2016
Table 25 : Eli Lilly and Company's Revenue, 2015-2016
Table 26 : GlaxoSmithKline's Revenue, 2015-2016
Table 27 : Hikma Pharmaceutical's Revenue, 2015-2016
Table 28 : J&J's Revenue, 2015-2016
Table 29 : Merck & Co., Inc.'s Net Revenue, 2014-2016
Table 30 : Myriad Genetics, Inc.'s Revenue, 2015-2016
Table 31 : Novartis AG's Revenue, 2015-2016
Table 32 : Pfizer, Inc.'s Net Revenue, 2014-2016
Table 33 : Quest Diagnostics, Inc.'s Revenue, 2015-2016
Table 34 : Roche Holding's Revenue, 2015-2016
Table 35 : Avastin's Drug Revenue, 2015-2016
List of Figures
Summary Figure A : Global Ovarian Cancer Therapeutic Market, by Cancer Type, 2016-2022
Summary Figure B : Global Ovarian Cancer Therapeutic Market, by Region, 2016-2022
Figure 1 : Woman's Reproductive System
Figure 2 : Ovarian Cancer Symptoms
Figure 3 : Pelvic Examination
Figure 4 : Transvaginal Ultrasound (TVUS)
Figure 5 : Pelvic Examination
Figure 6 : Global Market for FDA Cleared/Approved Companion Diagnostic Devices for Cancer, 2016-2022
Figure 7 : Global Market for FDA Cleared/Approved Companion Diagnostic Devices for Ovarian Cancer, 2016-2022
Figure 8 : Epithelial Cancer Therapy Market, 2016-2022
Figure 9 : Germ Cell Cancer Therapy Market, 2016-2022
Figure 10 : Stromal Cancer Therapy Market, 2016-2022
Figure 11 : Primary Peritoneal Cancer Therapy Market, 2016-2022
Figure 12 : Stage 1 and Substages of Ovarian Cancer
Figure 13 : Stage 2 and Substages of Ovarian Cancer
Figure 14 : Stage 3 and Substages of Ovarian Cancer
Figure 15 : Stage 4 and Substages of Ovarian Cancer
Figure 16 : U.S. Ovarian Cancer Therapeutics Market, 2016-2022
Figure 17 : Canada Ovarian Cancer Therapy Market, 2016-2022
Figure 18 : Germany Ovarian Cancer Therapy Market, 2016-2022
Figure 19 : U.K. Ovarian Cancer Therapy Market, 2016-2022
Figure 20 : France Ovarian Cancer Therapy Market, 2016-2022
Figure 21 : Italy Ovarian Cancer Therapy Market, 2016-2022
Figure 22 : Spain Ovarian Cancer Therapy Market, 2016-2022
Figure 23 : RoE Ovarian Cancer Therapy Market, 2016-2022
Figure 24 : India Ovarian Cancer Therapy Market, 2016-2022
Figure 25 : China Ovarian Cancer Therapy Market, 2016-2022
Figure 26 : Japan Ovarian Cancer Therapy Market, 2016-2022
Figure 27 : Middle East and Africa Ovarian Cancer Therapy Market, 2016-2022
Figure 28 : Mexico Ovarian Cancer Therapy Market, 2016-2022
Figure 29 : Lurbinectedin Chemical Structure
Figure 30 : Velaparib Chemical Structure
Figure 31 : Trametinib (Mekinist) Chemical Structure
Figure 32 : Fosbretabulin Chemical Structure
Figure 33 : Mirvetuximab Soravtansine Chemical Structure
Figure 34 : ONX-0801 Chemical Structure
Figure 35 : CancerSEEK Test
Figure 36 : Global Sales at Risk from Patent Expiration, 2016-2022
Figure 37 : Global Market Share of Major Players in OC Therapy Industry, 2016
Figure 38 : Merck & Co., Inc.'s Revenue Share, by Business Segment, 2016
Figure 39 : Merck & Co., Inc. Revenue Share, by Region, 2016
Figure 40 : Pfizer, Inc.'s Revenue Share, by Region, 2016
Figure 41 : Pfizer, Inc.'s Revenue Share, by Business Segment, 2016
Global Surgical Overalls Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Surgical Overalls market was valued at US$ 679.9 million in 2023 and is anticipated to reach US$ 870.5 million by 2030, witnessing a CAGR of 3.1% during The forecast period 2024-2030.
According to our research, The global market for medical devices is estimated at US$ 603 billion in The year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of The global GDP and is continuously rising in recent years ......
Global Medical or Healthcare Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 110
According to our LPI (LP Information) latest study, the global Medical or Healthcare market size was valued at US$ million in 2023. With growing demand in downstream market, the Medical or Healthcare is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Medical or Healthcare market. Medical or Healthcare are expected to show stable growth in the future market. However, product differ......
Global Hospital Gas Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 100
According to our LPI (LP Information) latest study, the global Hospital Gas market size was valued at US$ million in 2023. With growing demand in downstream market, the Hospital Gas is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Hospital Gas market. Hospital Gas are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Nurse Call Systems Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 135
According to our LPI (LP Information) latest study, the global Nurse Call Systems market size was valued at US$ 1633.1 million in 2023. With growing demand in downstream market, the Nurse Call Systems is forecast to a readjusted size of US$ 3280.4 million by 2030 with a CAGR of 10.5% during review period.
The research report highlights the growth potential of the global Nurse Call Systems market. Nurse Call Systems are expected to show stable growth in the future market. However, product......
Global Pediatric Healthcare Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 118
According to our LPI (LP Information) latest study, the global Pediatric Healthcare market size was valued at US$ 136230 million in 2023. With growing demand in downstream market, the Pediatric Healthcare is forecast to a readjusted size of US$ 177330 million by 2030 with a CAGR of 3.8% during review period.
The research report highlights the growth potential of the global Pediatric Healthcare market. Pediatric Healthcare are expected to show stable growth in the future market. However, ......
Global Telepharmacy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 100
Market Overview of Global Telepharmacy market:
According to our latest research, the global Telepharmacy market looks promising in the next 5 years. As of 2022, the global Telepharmacy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Telepharmacy market, with a systema......
Global Vinca Alkaloid Compounds Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 115
Market Overview of Global Vinca Alkaloid Compounds market:
According to our latest research, the global Vinca Alkaloid Compounds market looks promising in the next 5 years. As of 2022, the global Vinca Alkaloid Compounds market was estimated at USD 26.93 million, and it's anticipated to reach USD 44.76 million in 2028, with a CAGR of 8.84% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of th......
Global Bladder Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 116
Market Overview of Global Bladder Cancer market:
According to our latest research, the global Bladder Cancer market looks promising in the next 5 years. As of 2022, the global Bladder Cancer market was estimated at USD 3886.47 million, and it's anticipated to reach USD 13709.57 million in 2028, with a CAGR of 23.38% during the forecast years.
Bladder cancer is a disease in which cells in the urinary bladder start growing abnormally and uncontrollably. The main types of bladde......
Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 115
Market Overview of Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market:
According to our latest research, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market looks promising in the next 5 years. As of 2022, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
